Yikelong Docusate Sodium Tablets

Brand Name: 沂可隆®(Yikelong®)
Generic Name: Docusate Sodium
Strength: 100 mg per tablet
Manufacturer: HUNAN WARNER PHARMACEUTICAL CO., LTD.
Marketing Authorization Holder: HUNAN WARNER PHARMACEUTICAL CO., LTD.
Approval Date in China: 2008‑04‑15
Registration Number: National Drug Approval No. H20080620
Storage: Store in sealed and dry place, protected from light

Price&Cost:Contact Us now for the best price of Docusate Sodium(Yikelong)

1. Indications and Usage
Constipation: Short-term treatment of occasional constipation.
Fecal Softening: Indicated for patients with anorectal conditions (e.g., hemorrhoids, anal fissures) or post-surgical patients who require stool softening to avoid straining during defecation.
2. Dosage and Administration
Adults: The usual dosage is 50 to 200 mg daily, taken in divided doses. The maximum daily dose should not exceed 500 mg.
Children: The dosage is typically 5 mg/kg per day, administered in multiple divided doses.
Administration: Tablets should be taken orally. It usually takes 1 to 3 days to take effect.
Duration: For occasional constipation, treatment should not exceed 1 week unless directed by a physician.
3. Mechanism of Action
Surface Tension Reduction: Docusate sodium is an anionic surfactant that lowers the surface tension of the liquid in the intestine.
Stool Softening: This action allows water and lipids to penetrate the feces, softening them and making them easier to pass.
4. Safety and Warnings
Contraindications: Contraindicated in patients with nausea, vomiting, abdominal pain, or intestinal obstruction.
Pregnancy and Lactation: Contraindicated in pregnant and breastfeeding women due to potential risks.
Precautions: Prolonged use may lead to diarrhea, electrolyte imbalance, or laxative dependence.
5. Adverse Reactions and Clinical Research
Common Adverse Reactions: Occasional gastrointestinal discomfort, mild abdominal cramping, or diarrhea may occur.
Serious Effects: Long-term use may lead to severe diarrhea and dehydration.
6. Drug Interactions
Increased Absorption: Concomitant use with mineral oil may increase the absorption of mineral oil into the intestinal mucosa, potentially enhancing its toxicity.
Other Medications: It may increase the absorption or hepatic uptake of other drugs, potentially enhancing their effects or causing adverse reactions.
7. Pharmaceutical Information
Active Ingredient: Docusate Sodium (Sodium 1,4-bis(2-ethylhexyl)sulfosuccinate).
Strength: Typically 50 mg or 100 mg per tablet.
Appearance: White or almost white tablets.
Storage: Store in a tightly closed, light-resistant container, protected from moisture.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.